特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
962935

ゲノムバイオマーカーの世界市場(2020年~2027年):アプリケーション別(がん、心血管疾患、神経疾患、その他)、エンドユーザー別(診断および調査、病院、その他)、地域別の市場規模調査と予測

Global Genomic Biomarkers Market Size study, by Application (Oncology, Cardiovascular diseases, Neurological diseases, Others), by End-User (Diagnostic and research laboratories, Hospitals, Others) and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
ゲノムバイオマーカーの世界市場(2020年~2027年):アプリケーション別(がん、心血管疾患、神経疾患、その他)、エンドユーザー別(診断および調査、病院、その他)、地域別の市場規模調査と予測
出版日: 2020年10月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノムバイオマーカーの市場規模は2019年に約35億米ドルとなり、2020年~2027年の予測期間中に12.5%を超える健全な成長率で成長すると予想されています。ゲノムバイオマーカーは、デオキシリボ核酸(DNA)とリボ核酸(RNA)の属性を持っており、これらは通常、疾患の指標、疾患の分類、および治療の品揃えとして使用されます。これらは、一般に画像技術に適用される低侵襲または非侵襲のツールであり、癌性腫瘍やその他の合併症の鮮明な画像を提供し、CTスキャンおよびMRIスキャン全体での放射線治療の可能性を減らします。これらのバイオマーカーは、高カリウム血症、高血圧、およびその他の単一遺伝子の状況を評価するためにさらに利用されます。それらは、遺伝子の機能、遺伝子の発現、および典型的な生物学的手順、病原性手順、および治療への応答における遺伝子の監視を明らかにします。

ゲノムバイオマーカー市場の成長は、遺伝子発現プロファイリング(マイクロアレイ)や次世代シーケンシング(NGS)などのゲノムバイオマーカーの技術的進歩が世界中で絶え間なく拡大しているという事実に大きく起因しています。さらに、癌や心臓障害などの慢性疾患の有病率の上昇と相関した、ゲノムバイオマーカー研究への資金提供の利用可能性の高まりは、予測期間中の市場のCAGRに関与する他のいくつかの要因です。米国心臓協会によると、CVDは世界的に主要な死因です。 2016年に登録されたCVDによる死亡者数は約1,760万人で、2030年までに約2,360万人増加する可能性があります。2018年には約1,700万人の新しい癌の症例と950万人の死亡ケースがあり、この数は2040年までに2,750万人の新たな癌の症例と1,630万人の死亡ケースに増えると予想されています。これにより、世界的に市場の成長が強化されると予想されます。ただし、バイオマーカーを検証するための標準化の欠如と相まって厳格な政府規制は、2020年~2027年の予測期間にわたって市場の成長を抑制するいくつかの要因です。

当レポートではゲノムバイオマーカーの世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、アプリケーション・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の定義と範囲

第3章 市場力学

  • 市場の影響分析(2018年~2027年)

第4章 業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 アプリケーション別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析別
  • 見積もりと予測:2017年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 腫瘍学
    • 心血管疾患
    • 神経疾患
    • その他

第6章 エンドユーザー別

  • 市場のスナップショット
  • パ潜在的な分析別
  • 見積もりと予測:2017年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 診断および調査機関
    • 病院
    • その他

第7章 地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情勢

  • トップ市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Aepodia SA
    • Myriad Genetics Inc.
    • Eurofins Scientific
    • Qiagen
    • Bio-Rad Laboratories Inc.
    • Almac Group
    • Aros Applied Biotechnology A/S
    • EpiGenomic AG

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Genomic Biomarkers market, report scope
  • TABLE 2. Global Genomic Biomarkers market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Genomic Biomarkers market estimates & forecasts by Application 2017-2027 (USD Billion)
  • TABLE 4. Global Genomic Biomarkers market estimates & forecasts by End-User 2017-2027 (USD Billion)
  • TABLE 5. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 6. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Genomic Biomarkers market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Genomic Biomarkers market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. U.S. Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. U.S. Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 23. U.S. Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 24. Canada Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 25. Canada Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 26. Canada Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 27. UK Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 28. UK Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 29. UK Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. Germany Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 31. Germany Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. Germany Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 33. France Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 34. France Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. France Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. Spain Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 37. Spain Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. Spain Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. Italy Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 40. Italy Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 41. Italy Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. ROE Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 43. ROE Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. ROE Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. China Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 46. China Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. China Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. India Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 49. India Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. India Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. Japan Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 52. Japan Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 53. Japan Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Australia Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 55. Australia Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. Australia Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 57. South Korea Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 58. South Korea Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 59. South Korea Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. ROPAC Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 61. ROPAC Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 62. ROPAC Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. Brazil Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 64. Brazil Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 65. Brazil Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. Mexico Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 67. Mexico Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 68. Mexico Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 69. ROLA Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 70. ROLA Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 71. ROLA Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 72. ROW Genomic Biomarkers market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 73. ROW Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 74. ROW Genomic Biomarkers market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. List of secondary sources, used in the study of global Genomic Biomarkers market
  • TABLE 76. List of primary sources, used in the study of global Genomic Biomarkers market
  • TABLE 77. Years considered for the study
  • TABLE 78. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Genomic Biomarkers market, research methodology
  • FIG 2. Global Genomic Biomarkers market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Genomic Biomarkers market, key trends 2019
  • FIG 5. Global Genomic Biomarkers market, growth prospects 2020-2027
  • FIG 6. Global Genomic Biomarkers market, porters 5 force Model
  • FIG 7. Global Genomic Biomarkers market, pest analysis
  • FIG 8. Global Genomic Biomarkers market, value chain analysis
  • FIG 9. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Genomic Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Genomic Biomarkers market, regional snapshot 2017 & 2027
  • FIG 18. North America Genomic Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 19. Europe Genomic Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Genomic Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 21. Latin America Genomic Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 22. Global Genomic Biomarkers market, company market share analysis (2019)
目次

Global Genomic Biomarkers Market is valued approximately at USD 3.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2027. Genomic biomarkers possess the attribute of Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) that are typically used as a disease indicator, disease classification, and therapy assortment. They are minimally or non-invasive tools generally applied in imaging technology to deliver clear imaging of cancerous tumors & other complications, as well as reduce the possibilities of radiation treatment throughout CT scans and MRI scans. These biomarkers are further utilized to assess hyperkalemia, high blood pressure, and other monogenic circumstances. They reveal the function of gene, manifestation of a gene, and supervision of a gene in typical biologic procedures, pathogenic procedures, and responses to therapeutics. The increase in the genomic biomarker market is significantly imputed to the fact that the technological advancements in genomic biomarker, such as Gene Expression Profiling (microarray) and Next-Generation Sequencing (NGS, is relentlessly expanding across the globe. Moreover, the rise in prevalence of chronic diseases such as cancer and cardiac disorder aligned with rising availability of funding for genomic biomarker research are the few other factors responsible for the CAGR of the market during the forecast period. According to the American Heart Association, CVD is the leading cause of death around the world. There were about 17.6 million deaths due to CVD registered in 2016, which is likely to grow almost 23.6 million by 2030. While there were around 17 million new cases of cancer and 9.5 million deaths were totaled in 2018 and is expecting to grow over 27.5 million new cancer cases and 16.3 million deaths by the year 2040. This, in turn, is expected to strengthen the market growth all over the world. However, the stringent government regulation coupled with the lack of standardization for validating the biomarker are the few factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Genomic Biomarkers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the supportive government policies and funding for genomic biomarker research along with the presence of a significant number of market vendors in the region. Whereas North America is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and cardiology diseases along with the presence of significant pharmaceutical and biotechnological infrastructure in the United States and Canada would create lucrative growth prospects for the Genomic Biomarkers market across the Asia-Pacific region.

Major market player included in this report are:

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd.

Aepodia SA

Myriad Genetics Inc.

Eurofins Scientific

Qiagen

Bio-Rad Laboratories Inc.

Almac Group

Aros Applied Biotechnology A/S

Epigenomics AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Oncology

Cardiovascular diseases

Neurological diseases

Others

By End-User:

Diagnostic and research laboratories

Hospitals

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Genomic Biomarkers Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Genomic Biomarkers Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Genomic Biomarkers Market, by Application, 2018-2027 (USD Billion)
    • 1.2.3. Genomic Biomarkers Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Genomic Biomarkers Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Genomic Biomarkers Market Dynamics

  • 3.1. Genomic Biomarkers Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Genomic Biomarkers Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Genomic Biomarkers Market, by Application

  • 5.1. Market Snapshot
  • 5.2. Global Genomic Biomarkers Market by Application, Performance - Potential Analysis
  • 5.3. Global Genomic Biomarkers Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
  • 5.4. Genomic Biomarkers Market, Sub Segment Analysis
    • 5.4.1. Oncology
    • 5.4.2. Cardiovascular diseases
    • 5.4.3. Neurological diseases
    • 5.4.4. Others

Chapter 6. Global Genomic Biomarkers Market, by End-User

  • 6.1. Market Snapshot
  • 6.2. Global Genomic Biomarkers Market by End-User - Potential Analysis
  • 6.3. Global Genomic Biomarkers Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 6.4. Genomic Biomarkers Market, Sub Segment Analysis
    • 6.4.1. Diagnostic and research laboratories
    • 6.4.2. Hospitals
    • 6.4.3. Others

Chapter 7. Global Genomic Biomarkers Market, Regional Analysis

  • 7.1. Genomic Biomarkers Market, Regional Market Snapshot
  • 7.2. North America Genomic Biomarkers Market
    • 7.2.1. U.S. Genomic Biomarkers Market
      • 7.2.1.1. Application breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Genomic Biomarkers Market
  • 7.3. Europe Genomic Biomarkers Market Snapshot
    • 7.3.1. U.K. Genomic Biomarkers Market
    • 7.3.2. Germany Genomic Biomarkers Market
    • 7.3.3. France Genomic Biomarkers Market
    • 7.3.4. Spain Genomic Biomarkers Market
    • 7.3.5. Italy Genomic Biomarkers Market
    • 7.3.6. Rest of Europe Genomic Biomarkers Market
  • 7.4. Asia-Pacific Genomic Biomarkers Market Snapshot
    • 7.4.1. China Genomic Biomarkers Market
    • 7.4.2. India Genomic Biomarkers Market
    • 7.4.3. Japan Genomic Biomarkers Market
    • 7.4.4. Australia Genomic Biomarkers Market
    • 7.4.5. South Korea Genomic Biomarkers Market
    • 7.4.6. Rest of Asia Pacific Genomic Biomarkers Market
  • 7.5. Latin America Genomic Biomarkers Market Snapshot
    • 7.5.1. Brazil Genomic Biomarkers Market
    • 7.5.2. Mexico Genomic Biomarkers Market
  • 7.6. Rest of The World Genomic Biomarkers Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Thermo Fisher Scientific Inc.
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. F. Hoffmann-La Roche Ltd.
    • 8.2.3. Aepodia SA
    • 8.2.4. Myriad Genetics Inc.
    • 8.2.5. Eurofins Scientific
    • 8.2.6. Qiagen
    • 8.2.7. Bio-Rad Laboratories Inc.
    • 8.2.8. Almac Group
    • 8.2.9. Aros Applied Biotechnology A/S
    • 8.2.10. EpiGenomic AG

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.